261 related articles for article (PubMed ID: 11417607)
1. Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols.
Haspolat S; Anlar B; Köse G; Coskun M; Yegin O
J Child Neurol; 2001 Jun; 16(6):417-20. PubMed ID: 11417607
[TBL] [Abstract][Full Text] [Related]
2. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.
Gascon GG;
J Child Neurol; 2003 Dec; 18(12):819-27. PubMed ID: 14736075
[TBL] [Abstract][Full Text] [Related]
3. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.
Yalaz K; Anlar B; Oktem F; Aysun S; Ustacelebi S; Gurcay O; Gucuyener K; Renda Y
Neurology; 1992 Mar; 42(3 Pt 1):488-91. PubMed ID: 1372397
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with adult-onset subacute sclerosing panencephalitis.
Eroglu E; Gokcil Z; Bek S; Ulas UH; Ozdag MF; Odabasi Z
J Neurol Sci; 2008 Dec; 275(1-2):113-6. PubMed ID: 18783800
[TBL] [Abstract][Full Text] [Related]
5. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis.
Aydin OF; Senbil N; Kuyucu N; Gürer YK
J Child Neurol; 2003 Feb; 18(2):104-8. PubMed ID: 12693776
[TBL] [Abstract][Full Text] [Related]
7. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report.
Han CY; Lin HF; Shin PY; Liu CK; Liu CS
Kaohsiung J Med Sci; 2003 Aug; 19(8):416-20. PubMed ID: 12962429
[TBL] [Abstract][Full Text] [Related]
8. [Therapy and prognosis in subacute sclerosing panencephalitis].
Hosoya M
Nihon Rinsho; 2007 Aug; 65(8):1483-6. PubMed ID: 17695288
[TBL] [Abstract][Full Text] [Related]
9. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.
Gascon G; Yamani S; Crowell J; Stigsby B; Nester M; Kanaan I; Jallu A
Brain Dev; 1993; 15(5):346-55. PubMed ID: 7506498
[TBL] [Abstract][Full Text] [Related]
10. Intraventricular administration of interferon and administration of methisoprinol by mouth in the treatment of adult-onset subacute sclerosing panencephalitis.
Harbord MG; Jones T; Hicks EP; Blumbergs PC
Med J Aust; 1988 May; 148(9):467-9, 473. PubMed ID: 2452337
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis.
Tekgül H; Tutuncuoglu S; Kutukçuler N; Dizdarer G; Huseyinov A
J Child Neurol; 1999 Jul; 14(7):418-21. PubMed ID: 10573462
[TBL] [Abstract][Full Text] [Related]
12. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis.
Anlar B; Yalaz K; Köse G; Saygi S
J Child Neurol; 1998 Nov; 13(11):557-9. PubMed ID: 9853649
[TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon in the treatment of subacute sclerosing panencephalitis.
Fayad MN; Yamout BI; Mroueh S
J Child Neurol; 1997 Nov; 12(8):486-8. PubMed ID: 9430312
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon.
Anlar B; Yalaz K; Oktem F; Köse G
Neurology; 1997 Feb; 48(2):526-8. PubMed ID: 9040751
[TBL] [Abstract][Full Text] [Related]
15. [Five patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon and inosinpranobex].
Oshiro S; Minema H; Shiroma N; Hirayasu K; Nakada Y
No To Hattatsu; 2004 Jan; 36(1):70-4. PubMed ID: 14737868
[TBL] [Abstract][Full Text] [Related]
16. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
Gupta E; Dar L; Singh S; Behari M; Broor S
Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
[TBL] [Abstract][Full Text] [Related]
17. Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis.
Anlar B; Aydin OF; Guven A; Sonmez FM; Kose G; Herguner O
Clin Ther; 2004 Nov; 26(11):1890-4. PubMed ID: 15639700
[TBL] [Abstract][Full Text] [Related]
18. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis.
Gokcil Z; Odabasi Z; Demirkaya S; Eroglu E; Vural O
J Neurol Sci; 1999 Jan; 162(1):62-4. PubMed ID: 10064170
[TBL] [Abstract][Full Text] [Related]
19. Improvement of SSPE by intrathecal infusion of alpha-IFN.
Kurata T; Matsubara E; Yokoyama M; Nagano I; Shoji M; Abe K
Neurology; 2004 Jul; 63(2):398-9. PubMed ID: 15277654
[No Abstract] [Full Text] [Related]
20. Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Mehta SP; Sobczyk W; Coyle PK; Sersen EA; Wisniewski HM
Clin Immunol Immunopathol; 1992 Oct; 65(1):53-9. PubMed ID: 1382909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
